Natural progression of dysplasia in adult recurrent respiratory papillomatosis

Otolaryngology - Head and Neck Surgery

Volumn 144, Issue 2, 2011, Pages 252-256

  Hall, Joseph E ^a   Chen, Karen ^a   Yoo, Mi Jin ^a   Fletcher, Kenneth C ^a   Ossoff, Robert H ^a   Garrett, C Gaelyn ^a  

^a Vanderbilt Voice Center   (United States)

Author keywords

Dysplasia; HPV; Natural progression; Progression; RRP

Indexed keywords

ADULT; ARTICLE; CANCER GROWTH; CARCINOMA IN SITU; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DYSPLASIA; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 59; MAJOR CLINICAL STUDY; MALE; PAPILLOMATOSIS; RECURRENT RESPIRATORY PAPILLOMATOSIS; RESPIRATORY TRACT TUMOR; SMOKING; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE; BIOPSY; COMPARATIVE STUDY; FOLLOW UP; HOSPITALIZATION; HYPERPLASIA; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PROGNOSIS; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT MUCOSA; RETROSPECTIVE STUDY;

ADULT; BIOPSY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; RESPIRATORY MUCOSA; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 79959620895     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599810391626     Document Type: Article

References (10)

1. Go C, Schwartz MR, Donovan DT. Molecular transformation of recurrent respiratory papillomatosis: viral typing and p53 overexpression. Ann Otol Rhinol Laryngol. 2003;112(4):298-302. (Pubitemid 36438024)
2. Preuss SF, Klussmann JP, Jungehulsing M, et al. Long-term results of surgical treatment for recurrent respiratory papillomatosis. Acta Otolaryngol. 2007;127(11):1196-1201. (Pubitemid 47608899)
3. Lee LA, Cheng AJ, Fang TJ, et al. High incidence of malignant transformation of laryngeal papilloma in Taiwan. Laryngoscope. 2008;118(1):50-55.
4. Rady PL, Schnadig VJ, Weiss RL, et al. Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53. Laryngoscope. 1998;108(5):735-740. (Pubitemid 28213498)
5. Shehab N, Sweet B, Hogikyan D. Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature. Pharmacotherapy. 2005;25:977-989. (Pubitemid 40917930)
6. Robinson RA, Gupta H, Karnell LH, et al. Commentary on "Dysplasia in adults with recurrent respiratory papillomatosis: incidence and risk factors." Ann Otol Rhinol Laryngol. 2009;118(7):486-487.
7. Gupta HT, Robinson RA, Murray RC, et al. Degrees of dysplasia and the use of cidofovir in patients with recurrent respiratory papillomatosis. Laryngoscope. 2010;120(4):698-702.
8. Blumin J, Handler E, Simpson B, et al. Dysplasia in adults with recurrent respiratory papillomatosis: incidence and risk factors. Ann Otol Rhinol Laryngol. 2009;118(7):481-485.
9. Downs-Kelly E, Mendelin JE, Bennett AE, et al. Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies. Am J Gastroenterol. 2008;103(9):2333-2340.
10. Gale N, Pilch B, Sidransky D. Pathology and genetics of head and neck tumours. In: Barnes L, Eveson J, Reichart P, Sidransky D, eds. World Health Organization Classification of Tumours. Lyon, France: IARC Press; 2005;140-143.